Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON
  1. Homepagina
  2. Aandelen
  3. Canada
  4. Toronto Stock Exchange
  5. Acerus Pharmaceuticals Corporation
  6. Nieuws
  7. Overzicht
    ASP   CA00444G1081

ACERUS PHARMACEUTICALS CORPORATION

(ASP)
uitgestelde koers. Vertraagde tijd Toronto Stock Exchange - 15/10 23:00:00
0.04 CAD   --.--%
2020ACERUS PHARMACEUTICALS CORPORATION : RIGHTS ISSUE: 1 new share @ 0.025 CAD for 1.919841 existing shares
FA
OverzichtKoersenGrafiekenNieuwsAgendaOndernemingFinanciŽnBeursproducten 
 OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws over ACERUS PHARMACEUTICALS CORPORATION
2020ACERUS PHARMACEUTICALS CORPORATION : RIGHTS ISSUE: 1 new share @ 0.025 CAD for 1.919841 ex..
FA
Al het nieuws
Nieuws in andere talen op ACERUS PHARMACEUTICALS CORPORATION
23/08Acerus Announces Participation in HC Wainwright Conference
12/08ACERUS PHARMACEUTICALS : Reports Acceptance of Part 36 Settlement Offer in Recipharm Litig..
12/08Acerus Reports Acceptance of Part 36 Settlement Offer in Recipharm Litigation
10/08ACERUS PHARMACEUTICALS : Q2 EPS US$0.00 Vs Loss $0.01 a Year Ago; Provides Update and Outl..
10/08Acerus Reports Fiscal 2021 Second Quarter Financial Results
09/08ACERUS : Q2 Earnings Snapshot
09/08Acerus Pharmaceuticals Corporation Reports Earnings Results for the Second Quarter Ende..
03/08Acerus to Report Q2-2021 Financial Results and Host Investor Call
12/07ACERUS PHARMACEUTICALS : Says Legal Battle with Manufacturing Partner Recipharm Headed to ..
12/07Acerus Provides Update on Litigation with Recipharm
Meer nieuws
Bedrijfsnieuws
23/08Acerus Announces Participation in HC Wainwright Conference
GL
12/08Acerus Reports Acceptance of Part 36 Settlement Offer in Recipharm Litigation
GL
10/08Acerus Reports Fiscal 2021 Second Quarter Financial Results
GL
09/08ACERUS : Q2 Earnings Snapshot
AQ
03/08Acerus to Report Q2-2021 Financial Results and Host Investor Call
GL
Meer persberichten
Volgende evenement op ACERUS PHARMACEUTICALS CORPORATION
Komende gebeurtenissen in de sector